News | February 07, 2007

MR Angiography Highly Accurate for Identifying Blockages to Brain

Feb. 9, 2007 — Blockages in arteries that carry blood to the brain are clearly visible to physicians using contrast-enhanced magnetic resonance (MR) angiography, according to a study in the February issue of Radiology published by the Radiological Society of North America.

Eighty patients (44 men and 36 women) with suspected arterial occlusive disease were included in the study, which compared the performance of contrast-enhanced MR angiography to DSA and CT angiography. Two independent readers evaluated the images.

"Contrast-enhanced MR angiography provided highly accurate information about the supra-aortic arteries," said Kambiz Nael, M.D., research fellow and radiology resident at the David Geffen School of Medicine at UCLA in Los Angeles. "MR angiography produced results comparable to the gold standard of digital subtraction angiography (DSA) and multidetector computed tomography (CT) angiography. In addition, this technology produced images with higher resolution over a larger field of view in a shorter amount of time than previous contrast-enhanced MR angiography techniques," he said.

Blockages were detected with MR angiography in 208 segments of artery by the first reader and 218 by the second reader, correlating closely to the DSA and CT findings. In addition, MR angiography proved highly accurate (94 to 100 percent) for detecting blockages of over 50 percent, and image quality was rated sufficient to excellent for 97 percent of the arterial segments evaluated.

"MR angiography, using a small quantity of MRI dye injected into a vein in the arm, can produce detailed images of the arteries supplying the brain and can detect even minor degrees of narrowing or blockage. It does not involve exposure to x-rays and is widely regarded as a very safe, painless test," Dr. Nael said.

Dr. Nael predicts that in most cases, contrast-enhanced MR angiography could replace other diagnostic techniques for evaluation of all the arteries that supply blood to the brain.

"This procedure should be highly cost effective for clinical use, because of the speed and modest dose of contrast required," Dr. Nael said. "In the absence of contraindications to MRI, I would recommend MR angiography over DSA and CTA for routine use--avoiding increased risk of mini-stroke and radiation exposure."

"As the technology evolves, MR angiography will likely become even faster and more powerful," he said.

Related Content

Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
New MRI Technique Captures Brain Changes in Near-real Time

Differences in stiffness between stimulus states. Image courtesy of Patz et al.

News | Neuro Imaging | August 19, 2019
An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an...
ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n